Cholesterol-Lowering Therapy: Evaluation
β Scott M. Grundy
π Library
π
2000
π Marcel Dekker
π English
β¦ LIBER β¦
π
Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence
β Scribed by Scott M. Grundy (Editor)
- Publisher
- CRC Press
- Year
- 1999
- Leaves
- 348
- Edition
- 1
- Category
- Library
β¬ Acquire This Volume
No coin nor oath required. For personal study only.
β¦ Synopsis
Reveals important new results from clinical trials conducted in Scandinavia, Scotland, Australia, Canada, and the United States.
This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major risk factor in coronary heart disease (CHD). The studies p
β¦ Table of Contents
Cholesterol-Lowering Clinical Trials: A Historical Perspective
Scott M. Grundy
Scandinavian Simvastatin Survival Study (4S)
Terje R. Pedersen
The Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels
Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moye, C. Morton Hawkins, Barry R. Davis, Jean L. Rouleau, Thomas G. Cole, and Eugene Braunwald
Lessons from the West of Scotland Coronary Prevention Study (WOSCOPS)
James Shepherd and Allan Gaw
Program on the Surgical Control of the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year Study
Henry Buchwald
The Air Force/Texas Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Primary Prevention of Acute Major Coronary Events in Women and Men with Average Cholesterol
Stephen Weis, Michael Clearfield, Lt. Col. John R. Downs, and Antonio M. Gotto, Jr.
Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular Practice
Andrew M. Tonkin and David Hunt
Angiographic Results of Lipid-Lowering Trials: A Systematic Review and Meta-Analysis
Cheryl L. Holmes, Michael Schulzer, and G. B. John Mancini
Biochemical Correlates of Plaque Progression and Coronary Events
Melissa Ferraro-Borgida and David Waters
Lipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque: New Insights into the Prevention of Cardiovascular Events
B. Greg Brown and Xue-Qiao Zhao
Cholesterol-Lowering Trials with Carotid Ultrasonographic Outcomes
Robert P. Byington
Cholesterol Lowering Reduces Mortality: The Statins
David J. Gordon
β¦ Subjects
Bioscience;Nutrition;Pharmaceutical Science;Clinical Trials - Pharmaceutical Science
π SIMILAR VOLUMES
Cholesterol Busting Guide: Lowering Chol
β Anne V. Parsons
π Library
π
2014
π Speedy Publishing LLC
π English
This Cholesterol Busting Guide will put you in control of your cholesterol levels. You will learn the difference between the healthy cholesterol and the bad for your heart cholesterol. Soon you will know exactly which foods to avoid and which foods will lower your cholesterol naturally. You don't ha
Clinical Evaluation of Antitumor Therapy
β Franco M. Muggia, Marcel Rozencweig (auth.), Franco M. Muggia M.D., Marcel Rozen
π Library
π
1986
π Springer US
π English
<p>The methodology of drug development has been the subject of extensive disΒ cussion by a relatively small group of individuals in industry and government who have been intimately concerned with the identification and study of new anticancer drugs. The Chemotherapy Program of the National Cancer In
Developments in Statistical Evaluation o
β Kees van Montfort, Johan Oud, Wendimagegn Ghidey (eds.)
π Library
π
2014
π Springer-Verlag Berlin Heidelberg
π English
<p><p>This book describes various ways of approaching and interpreting the data produced by clinical trial studies, with a special emphasis on the essential role that biostatistics plays in clinical trials.</p>Over the past few decades the role of statistics in the evaluation and interpretation of c
Economic Evaluation in Clinical Trials
β Henry A. Glick, Jalpa A. Doshi, Seema S. Sonnad, Daniel Polsky
π Library
π
2014
π Oxford University Press
π English
It is becoming increasingly important to examine the relationship between the outcomes of a clinical trial and the costs of the medical therapy under study. The results of such analysis can affect reimbursement decisions for new medical technologies, drugs, devices or diagnostics. It can aid compani
Review of the Fialuridine (FIAU) Clinica
β Committee to Review the Fialuridine (FIAU FIAC) Clinical Trials, Institute of Me
π Library
π
1995
π National Academies Press
π English
In June 1993, a clinical trial of fialuridine (FIAU), a promising new medication for hepatitis B, was abruptly terminated when one of the 15 out-patients participating in the National Institutes of Health (NIH) study was suddenly hospitalized with liver failure. Although, all the remaining patients